Rating History for Bicara Therapeutics Inc (BCAX) by BMO Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | David Lebowitz | New Coverage | Outperform (N/A) |
35.00 (N/A) |
24.94 (23.42) |
-6.09% | Details |
